TargetCancer Foundation’s funded research in rare cancers has yielded groundbreaking discoveries published in numerous peer-reviewed journals. This consistent contribution to rare cancer knowledge underscores our commitment to expertise, authoritative research, and trustworthy information in the rare cancer community.
Featured Publication
“Generation of a Biliary Tract Cancer Cell Line Atlas Identifies Molecular Subtypes and Therapeutic Targets” Cancer Discovery – Read Article
Kras-G12D and p53 Mutation Cause Primary Intrahepatic Cholangiocarcinoma
January 2012Cancer Research